Hyponatremia and SIADH from SSRIs

Mechanism

SSRIs increase antidiuretic hormone (ADH, vasopressin) secretion by mechanisms not fully understood, likely involving central serotonergic effects on ADH-releasing neurons. Elevated ADH causes water retention out of proportion to sodium, diluting serum sodium. Classic SIADH picture: low serum sodium, low serum osmolality, inappropriately concentrated urine, euvolemic clinical exam.

Risk factors

Highest risk:

• Age above 65 (often above 75)
• Female sex
• Low body weight
• Concurrent thiazide or loop diuretic use
• Concurrent other SIADH-inducing drugs (some anticonvulsants, opioids)
• Warm weather (increased fluid intake, sweating)
• Recent surgery
• Prior episode of SSRI-induced hyponatremia
• Nursing home or assisted living residency

Timing: Most cases occur within the first 2 weeks of treatment or dose increase. Late cases (months later) also occur, especially with fluid balance changes.

Which drugs

SSRIs: Roughly equivalent risk across sertraline, escitalopram, citalopram, paroxetine. Fluoxetine causes prolonged hyponatremia due to long half-life.

SNRIs: Venlafaxine and duloxetine cause SIADH at similar rates to SSRIs.

TCAs: Lower rates than SSRIs.

Antipsychotics: Some cases with typical and atypical antipsychotics.

Lower risk antidepressants: Bupropion (Wellbutrin), mirtazapine (Remeron), agomelatine, vortioxetine, vilazodone appear to cause much less SIADH.

Presentation

Silent (subclinical): Found only on routine labs. Sodium 130 to 134 range.

Mild: Nausea, headache, fatigue, cognitive slowing. Sodium 125 to 130.

Moderate: Confusion, gait instability, falls, dizziness. Sodium 120 to 125.

Severe: Seizures, coma, cerebral edema, respiratory arrest. Sodium below 120.

Elderly patients often present with falls, cognitive change, or "failure to thrive" rather than obvious hyponatremia symptoms. Any older adult on an SSRI with new confusion or falls warrants sodium check.

Management

Prevention: Check baseline sodium in older adults before starting an SSRI. Recheck at 2 weeks. Consider a lower-risk antidepressant (mirtazapine, bupropion) in patients with multiple risk factors.

Asymptomatic mild hyponatremia (Na 130 to 134):

• Recheck in 3 to 7 days
• Fluid restriction (usually 1 to 1.5 L per day)
• Continue SSRI if sodium stabilizes

Symptomatic or Na below 130:

• Stop the SSRI
• Fluid restriction
• Slow sodium correction (no more than 8 to 10 mEq/L per 24 hours to avoid osmotic demyelination syndrome)
• Address contributing factors (stop thiazides, reduce contributory drugs)
• Consider switch to non-SSRI antidepressant (mirtazapine, bupropion, vortioxetine)

Severe (Na below 120 with symptoms):

• ED evaluation
• Cautious hypertonic saline for symptomatic hyponatremia
• Slow correction
• ICU-level care if seizures or coma

Rechallenge: Some patients tolerate a different SSRI after prior SSRI-induced hyponatremia, but recurrence is common. Non-SSRI alternative is often safer.

Common questions

How common is SSRI hyponatremia in older adults? Prospective studies suggest 5 to 30 percent of older adults started on SSRI develop measurable hyponatremia within the first few weeks. Clinically significant hyponatremia (symptomatic or below 130) occurs in 1 to 5 percent.

Which is the safest antidepressant for sodium? Bupropion and mirtazapine have the lowest reported rates of SIADH. Vortioxetine and vilazodone also appear low. For patients with prior SSRI-induced hyponatremia or high risk, these are legitimate alternatives.

Can I keep taking my SSRI if my sodium is 132? Sometimes. For mild asymptomatic hyponatremia (130 to 134), fluid restriction and recheck is often adequate. Below 130 or symptomatic usually means stopping the SSRI.

Why is fluoxetine problematic if it's an SSRI like the others? Fluoxetine causes SIADH at roughly the same acute rate as other SSRIs, but its long half-life (parent 4 to 6 days, metabolite norfluoxetine up to 16 days) means the effect persists for weeks after stopping. Correcting hyponatremia during that clearance takes longer.

Are elderly patients on SSRIs at higher fall risk from this? Yes. Hyponatremia-related gait instability contributes to the well-documented increased fall risk in older adults on SSRIs. Some of the falls attributed to SSRI orthostasis or sedation may actually be sodium-related.

Should everyone starting an SSRI get a baseline sodium? For adults under 65 with no risk factors, routine screening is not standard. For adults over 65, especially with diuretic use, low weight, or other risk factors, baseline and 2-week sodium check is reasonable.

Does hyponatremia from an SSRI go away completely after stopping? Yes, in most cases. Sodium normalizes over 1 to 2 weeks after the SSRI is stopped (longer for fluoxetine).